Literature DB >> 23557244

Acute delivery of EphA4-Fc improves functional recovery after contusive spinal cord injury in rats.

Mark Damien Spanevello1, Sophie Ines Tajouri, Cornel Mirciov, Nyoman Kurniawan, Martin John Pearse, Louis Jerry Fabri, Catherine Mary Owczarek, Matthew Philip Hardy, Rebecca Anne Bradford, Melanie Louise Ramunno, Ann Maree Turnley, Marc Jan Ruitenberg, Andrew Wallace Boyd, Perry Francis Bartlett.   

Abstract

Blocking the action of inhibitory molecules at sites of central nervous system injury has been proposed as a strategy to promote axonal regeneration and functional recovery. We have previously shown that genetic deletion or competitive antagonism of EphA4 receptor activity promotes axonal regeneration and functional recovery in a mouse model of lateral hemisection spinal cord injury. Here we have assessed the effect of blocking EphA4 activation using the competitive antagonist EphA4-Fc in a rat model of thoracic contusive spinal cord injury. Using a ledged tapered balance beam and open-field testing, we observed significant improvements in recovery of locomotor function after EphA4-Fc treatment. Consistent with functional improvement, using high-resolution ex vivo magnetic resonance imaging at 16.4T, we found that rats treated with EphA4-Fc had a significantly increased cross-sectional area of the dorsal funiculus caudal to the injury epicenter compared with controls. Our findings indicate that EphA4-Fc promotes functional recovery following contusive spinal cord injury and provides further support for the therapeutic benefit of treatment with the competitive antagonist in acute cases of spinal cord injury.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23557244      PMCID: PMC3689926          DOI: 10.1089/neu.2012.2729

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  53 in total

1.  Experimental modeling of spinal cord injury: characterization of a force-defined injury device.

Authors:  Stephen W Scheff; Alexander G Rabchevsky; Isabella Fugaccia; John A Main; James E Lumpp
Journal:  J Neurotrauma       Date:  2003-02       Impact factor: 5.269

Review 2.  Behavioral tests for preclinical intervention assessment.

Authors:  Timothy Schallert
Journal:  NeuroRx       Date:  2006-10

3.  Expression profile and role of EphrinA1 ligand after spinal cord injury.

Authors:  Luz C Arocho; Johnny D Figueroa; Aranza I Torrado; José M Santiago; Ariel E Vera; Jorge D Miranda
Journal:  Cell Mol Neurobiol       Date:  2011-05-21       Impact factor: 5.046

4.  Blocking EphA4 upregulation after spinal cord injury results in enhanced chronic pain.

Authors:  Lillian Cruz-Orengo; Johnny D Figueroa; Ixane Velázquez; Aranza Torrado; Cristina Ortíz; Carmen Hernández; Anabel Puig; Annabell C Segarra; Scott R Whittemore; Jorge D Miranda
Journal:  Exp Neurol       Date:  2006-09-07       Impact factor: 5.330

5.  Rac-GAP alpha-chimerin regulates motor-circuit formation as a key mediator of EphrinB3/EphA4 forward signaling.

Authors:  Takuji Iwasato; Hironori Katoh; Hiroshi Nishimaru; Yukio Ishikawa; Haruhisa Inoue; Yoshikazu M Saito; Reiko Ando; Mizuho Iwama; Ryosuke Takahashi; Manabu Negishi; Shigeyoshi Itohara
Journal:  Cell       Date:  2007-08-24       Impact factor: 41.582

Review 6.  Behavioral outcome measures for the assessment of sensorimotor function in animal models of movement disorders.

Authors:  Sheila M Fleming
Journal:  Int Rev Neurobiol       Date:  2009       Impact factor: 3.230

7.  Structural characterization of the EphA4-Ephrin-B2 complex reveals new features enabling Eph-ephrin binding promiscuity.

Authors:  Haina Qin; Roberta Noberini; Xuelu Huan; Jiahai Shi; Elena B Pasquale; Jianxing Song
Journal:  J Biol Chem       Date:  2009-10-29       Impact factor: 5.157

8.  Regeneration-enhancing effects of EphA4 blocking peptide following corticospinal tract injury in adult rat spinal cord.

Authors:  Jez Fabes; Patrick Anderson; Caroline Brennan; Stephen Bolsover
Journal:  Eur J Neurosci       Date:  2007-10-26       Impact factor: 3.386

9.  EphA4 blockers promote axonal regeneration and functional recovery following spinal cord injury in mice.

Authors:  Yona Goldshmit; Mark D Spanevello; Sophie Tajouri; Li Li; Fiona Rogers; Martin Pearse; Mary Galea; Perry F Bartlett; Andrew W Boyd; Ann M Turnley
Journal:  PLoS One       Date:  2011-09-13       Impact factor: 3.240

10.  Structural plasticity of eph receptor A4 facilitates cross-class ephrin signaling.

Authors:  Thomas A Bowden; A Radu Aricescu; Joanne E Nettleship; Christian Siebold; Nahid Rahman-Huq; Raymond J Owens; David I Stuart; E Yvonne Jones
Journal:  Structure       Date:  2009-10-14       Impact factor: 5.006

View more
  20 in total

Review 1.  Therapeutic targeting of EPH receptors and their ligands.

Authors:  Andrew W Boyd; Perry F Bartlett; Martin Lackmann
Journal:  Nat Rev Drug Discov       Date:  2014-01       Impact factor: 84.694

2.  Nogo-A-Δ20/EphA4 interaction antagonizes apoptosis of neural stem cells by integrating p38 and JNK MAPK signaling.

Authors:  Jun-Ling Wang; Wei-Guang Chen; Jia-Jia Zhang; Chao-Jin Xu
Journal:  J Mol Histol       Date:  2021-02-08       Impact factor: 2.611

3.  Spinal cord injury and the neuron-intrinsic regeneration-associated gene program.

Authors:  Nitish D Fagoe; Jessica van Heest; Joost Verhaagen
Journal:  Neuromolecular Med       Date:  2014-10-01       Impact factor: 3.843

Review 4.  A novel miR17/protein tyrosine phosphatase-oc/EphA4 regulatory axis of osteoclast activity.

Authors:  Kin-Hing William Lau; Matilda H-C Sheng
Journal:  Arch Biochem Biophys       Date:  2018-05-17       Impact factor: 4.013

5.  Critical role of EphA4 in early brain injury after subarachnoid hemorrhage in rat.

Authors:  Ruiming Fan; Budbazar Enkhjargal; Richard Camara; Feng Yan; Lei Gong; Jiping Tang; Yangmei Chen; John H Zhang
Journal:  Exp Neurol       Date:  2017-07-08       Impact factor: 5.330

6.  rIgG1 Fc Hexamer Inhibits Antibody-Mediated Autoimmune Disease via Effects on Complement and FcγRs.

Authors:  Rolf Spirig; Ian K Campbell; Sandra Koernig; Chao-Guang Chen; Bonnie J B Lewis; Rebecca Butcher; Ineke Muir; Shirley Taylor; Jenny Chia; David Leong; Jason Simmonds; Pierre Scotney; Peter Schmidt; Louis Fabri; Andreas Hofmann; Monika Jordi; Martin O Spycher; Susann Cattepoel; Jennifer Brasseit; Con Panousis; Tony Rowe; Donald R Branch; Adriana Baz Morelli; Fabian Käsermann; Adrian W Zuercher
Journal:  J Immunol       Date:  2018-03-12       Impact factor: 5.422

Review 7.  Eph receptors and ephrins: therapeutic opportunities.

Authors:  Antonio Barquilla; Elena B Pasquale
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014-10-03       Impact factor: 13.820

8.  Serial Diffusion Tensor Imaging In Vivo Predicts Long-Term Functional Recovery and Histopathology in Rats following Different Severities of Spinal Cord Injury.

Authors:  Samir P Patel; Taylor D Smith; Jenna L VanRooyen; David Powell; David H Cox; Patrick G Sullivan; Alexander G Rabchevsky
Journal:  J Neurotrauma       Date:  2016-02-11       Impact factor: 5.269

Review 9.  Therapeutic potential of targeting the Eph/ephrin signaling complex.

Authors:  Nayanendu Saha; Dorothea Robev; Emilia O Mason; Juha P Himanen; Dimitar B Nikolov
Journal:  Int J Biochem Cell Biol       Date:  2018-10-19       Impact factor: 5.085

10.  NMR-Guided Design of Potent and Selective EphA4 Agonistic Ligands.

Authors:  Carlo Baggio; Anna Kulinich; Cassandra N Dennys; Rochelle Rodrigo; Kathrin Meyer; Iryna Ethell; Maurizio Pellecchia
Journal:  J Med Chem       Date:  2021-07-22       Impact factor: 8.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.